Rinucumab

CAS: 1569263-06-4 F: W:

Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].
Name	Rinucumab
CAS	1569263-06-4
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487.